Clinical Trial Update: Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer [Phase 2]

View source ↗

Summary

Phase II trial update evaluating camrelizumab with chemotherapy or anlotinib in advanced esophageal squamous cell carcinoma (Stage IV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Anlotinib (anlotinib)
• Camrelizumab (camrelizumab)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Stage IV Esophagus Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN